KMKarl Madaras-Kelly

Karl Madaras-Kelly

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Karl Madaras-Kelly has a total of 114 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Comparative effectiveness of oral antibiotics to treat uncomplicated urinary tract infections in male outpatients

    by Karl Madaras-Kelly, Jeremy Boyd, Laura Bond

    Aim: New IDSA guidelines define uncomplicated UTI (uUTI) as infection limited to the bladder in both men and women. This study compared the effectiveness of β-lactams, nitrofurantoin and trimethoprim/sulfamethoxazole (TMP/SMX) to fluoroquinolones for outpatient uUTI treatment in men. Materials & methods: A retrospective cohort of adult male outpatients diagnosed with uUTI during 2019–2021 in the Department of Veterans Affairs system was created. Inclusion required an Emergency Department, Urgent/Primary Care visit with ICD-10 documentation of UTI and a prescription of interest dispensed. Patients with recent UTI, hospitalization, infectious co-diagnosis, temperature >99.9 F, pyelonephritis or prostatitis, or for whom asymptomatic bacteriuria treatment was appropriate were excluded. Overlap weighting propensity scores and generalized estimating equation models assessed the relative risk of a subsequent UTI-related visit or hospitalization within 3–30 days with a new antibiotic dispensed. Results: A total of 45,442 males (mean [SD]) age 71.6 (12.7) years were treated at 130 VA medical centers. Treatment n (%) included: β-lactams 17,655 (38.9%), nitrofurantoin 8394 (18.5%), TMP/SMX 9709 (21.4%) and fluoroquinolones 9684 (21.3%). UTI-related return visits occurred in 5453 (12.0%) and UTI-related hospitalization occurred in 1431 (3.1%). The adjusted relative risk (aRR, [95% CI]) of a return visit compared with fluoroquinolones was higher for β-lactams (1.22, [1.02, 1.48]) and nitrofurantoin (1.47, [1.23, 1.74]) but not for TMP/SMX (0.99, [0.80, 1.23]). The aRR for UTI-related hospitalization was not different for β-lactams (1.06, [0.80, 1.40] or TMP/SMX [0.80, [0.56, 1.15], but was lower for nitrofurantoin [0.60, [0.41, 0.89]). Conclusion: Compared with fluoroquinolones, β-lactam and nitrofurantoin prescribed for outpatient uUTI were associated with modestly increased UTI-related return visits but not hospitalization in men.


  • Open Access

    A pilot intervention to improve the management of urinary tract infections in outpatient settings

    by Karl J. Madaras-Kelly, Trisha Nakasone, Saba Maghari, Janice Taylor, McKenna Nevers, Jacob Crook, Benjamin Brintz, Jordan B. Braunfeld, Matthew Bidwell Goetz, Matthew Samore

    Objective: To describe the implementation of an outpatient UTI intervention and its impact on UTI management. Design: Quasi-experimental retrospective controlled study. Participants: Outpatient clinicians practicing in emergency and primary care settings within 8 Veterans Affairs Medical Centers. Methods: An intervention conducted utilizing the CDC Core Elements Antibiotic Stewardship framework between September 2022 and July 2023. Actions included academic detailing, audit feedback, and updated reflex culture procedures. Logistic regression adjusted for covariates (risk ratio [RR], 95% confidence interval [CI]), and a difference-in-differences (DID) analysis compared multiple UTI management metrics between intervention and control facilities. Results: There were 278,419 and 157,067 genitourinary (GU) tract qualifying visits [mean (SD) age 71.7 (13.9), 92.6% male] within 8 intervention and 8 control sites, respectively. Antibiotic prescribing rates for a broad-based GU tract metric that included UTIs pre/post implementation were [ N, (%)] 12,688 (8.0) and 4,062 (8.0) within intervention sites and 5,686 (6.3) and 1,920 (6.8) within control sites, respectively [DID aRR 0.97 (0.92, 1.02)]. Appropriate treatment selection for uncomplicated UTI (uUTI) pre/post implementation was 5,994(76.9) and 1,945(79.9), compared to 2,519(74.6) and 977(82.1) within control sites, respectively [DID aRR 0.94 (0.91, 0.98)]. uUTI appropriate treatment duration pre/post implementation was 5,709 (73.3) and 1,927 (79.2), compared to 2,469 (73.1) and 869 (73.0) within control sites, respectively [DID aRR 1.08 (1.03, 1.13)]. No evidence of diagnostic shifting or return GU visits post-implementation was observed. Conclusions: Implementation of an outpatient UTI intervention in a predominantly male population was feasible but marginally effective.


  • Conceptual framework for prediction models of patient deterioration based on nursing documentation patterns: reproducibility and generalizability with a large number of hospitals across the United States

    by Yik-Ki Jacob Wan, Samir E. Abdelrahman, Julio C. Facelli, Karl Madaras-Kelly, Kensaku Kawamoto, Deniz Dishman, Samuel R. Himes, Kenrick Cato, Sarah C. Rossetti, Guilherme Del Fiol


  • Open Access

    The comparative effectiveness of telehealth versus primary care and collection of urine cultures on outcome in urinary tract infection

    by Karl J. Madaras-Kelly, Jeremy K. Boyd, Laura Bond

    Studies of urinary tract infection (UTI) treatment in telehealth settings have primarily evaluated young, healthy females. Urine culture collection is less common in telehealth settings but is recommended for all patients with potentially complicated infection. The aims of this study were: (1) to compare UTI-related clinical failure between telehealth and in-person primary care settings, and (2) evaluate if urine culture (UC) collection impacted UTI-related failure in patients with risk for antibiotic resistant infection. A retrospective cohort study of outpatients diagnosed with UTI between 2019 and 2021 in the Department of Veterans Affairs system was conducted. Inclusion required a telehealth or primary care visit with UTI International Classification of Diseases-Clinical Modification 10th revision code documentation and an antibiotic dispensed. Patients with recent UTI, concurrent indications for antibiotics, or where asymptomatic bacteriuria treatment was appropriate were excluded. Treatment failure was defined as combination of a new UTI-related outpatient visit or hospitalization that occurred between 3 to 30 days after the antibiotic dispense date. Antibiotic exposure data, covariates, hospitalization, and UC history were obtained. Overlap weighting and generalized estimating equation models estimated the relative risk of failure for clinical setting and for UC collection versus no collection. There were 16,266 telehealth and 29,296 primary care patient-visits evaluated. The adjusted relative risk (±95% CI) of failure for telehealth relative to primary care was [0.87 (0.70, 1.08)]. An interaction between setting and age ≥65 [1.45 (1.12, 1.87)] indicated higher failure for elderly patients treated for UTI in telehealth. Urine culture collection was associated with increased risk of failure for patients treated in telehealth [2.06 (1.56, 2.72)]; however, an interaction between UC collection and prior antibiotic exposure ≤90 days indicated a protective effect in both telehealth [0.70 (0.53, 0.93)] and primary care [0.77 (0.60, 0.99)] settings. Overall, no difference in the clinical failure rate for UTI treatment between telehealth and primary care was observed. However, elderly patients treated for UTI in telehealth experienced higher failure relative to in-person primary care. Patients with recent prior antibiotic exposure in both settings had lower clinical failure rates when UCs were collected.


  • Open Access

    Assessing hospital antibiotic stewardship program (ASP) implementation: validation of an implementation science-informed survey

    by Jorie Michaela Butler, Ellen Childs, Tamar Barlam, Mari-Lynn Drainoni, Caitlin Reardon, Yue Zhang, Laura Damschroder, Peter Taber, Karl Madaras-Kelly, Matthew Goetz, et al.

    Objective: Antibiotic stewardship programs (ASPs) are crucial to prevent the emergence of antibiotic resistance and to improve outcomes for patients. A validated instrument rooted in a theoretically derived implementation science framework will increase our understanding of ASP implementation and enable comparisons across implementation sites. Design: Methods: Antibiotic stewards (infectious disease pharmacists and physicians) were recruited from Veterans Affairs (VA) hospitals to complete a survey on stewardship implementation. We used the Consolidated Framework for Implementation Research (CFIR) to guide development of an ASP implementation survey assessing 22 potential determinants of implementation across five domains of CFIR. We conducted confirmatory factor analyses (CFA) to assess construct validity of 8 construct measures and evaluated internal consistency. Results: A total of 150 stewards completed the survey from 110 VA hospitals. CFA for most CFIR constructs exhibited good fit. Internal consistency for CFIR construct subscales (Cronbach’s alpha) ranged from 0.54–0.96, indicating modest to strong internal consistency. Determinants that were rated highly present at the sites (across site means ≥ 4.0 or above) included Self-Efficacy, Engaging, Evidence Strength and Quality and Relative Advantage, indicating stewards found ASP evidence compelling and felt their personal involvement was effective in engendering positive results for the ASP. Conclusions: Psychometric properties indicate validity of the first CFIR-based survey of determinants for ASP implementation outcomes. Clinical, quality improvement, and research teams can use this survey to identify contextual determinants of ASP implementation and use this information to guide selection of strategies and compare results across multiple sites.

  • Open Access

    Predicting antibiotic resistance in Enterobacterales to support optimal empiric treatment of urinary tract infections in outpatient veterans

    by Ben J. Brintz, Karl Madaras-Kelly, McKenna Nevers, Kelly L. Echevarria, Matthew B. Goetz, Matthew H. Samore

    Objective: Bacterial resistance is known to diminish the effectiveness of antibiotics for treatment of urinary tract infections. Review of recent healthcare and antibiotic exposures, as well as prior culture results is recommended to aid in selection of empirical treatment. However, the optimal approach for assessing these data is unclear. We utilized data from the Veterans Health Administration to evaluate relationships between culture and treatment history and the subsequent probability of antibiotic-resistant bacteria identified in urine cultures to further guide clinicians in understanding these risk factors. Methods: Using the XGBoost algorithm, a retrospective cohort of outpatients with urine culture results and antibiotic prescriptions from 2017 to 2022 was used to develop models for predicting antibiotic resistance for three classes of antibiotics: cephalosporins, fluoroquinolones, and trimethoprim/sulfamethoxazole (TMP/SMX) obtained from urine cultures. Model performance was assessed using Area Under the Receiver Operating Characteristic curve (AUC) and Precision-Recall AUC (PRAUC) Results: There were 392,647 prior urine cultures identified in 214,656 patients. A history of bacterial resistance to the specific treatment was the most important predictor of subsequent resistance for positive cultures, followed by a history of specific antibiotic exposure. The models performed better than previously established risk factors alone, especially for fluoroquinolone resistance, with an AUC of .84 and PRAUC of .70. Notably, the models’ performance improved markedly (AUC = .90, PRAUC = .87) when applied to cultures from patients with a known history of resistance to any of the antibiotic classes. Conclusion: These predictive models demonstrate potential in guiding antibiotic prescription and improving infection management.


  • Open Access

    Research agenda for antibiotic stewardship within the Veterans’ Health Administration, 2024–2028

    by Daniel J. Livorsi, Westyn Branch-Elliman, Dimitri Drekonja, Kelly L. Echevarria, Margaret A. Fitzpatrick, Matthew Bidwell Goetz, Christopher J. Graber, Makoto M. Jones, Allison A. Kelly, Karl Madaras-Kelly, et al.


  • Open Access

    A qualitative evaluation of frontline clinician perspectives toward antibiotic stewardship programs

    by Maria Tjilos, Mari-Lynn Drainoni, Shana A. B. Burrowes, Jorie M. Butler, Laura J. Damschroder, Matthew Bidwell Goetz, Karl Madaras-Kelly, Caitlin M. Reardon, Matthew H. Samore, Jincheng Shen, et al.

    Objective: To examine the perspectives of caregivers that are not part of the antibiotic stewardship program (ASP) leadership team (eg, physicians, nurses, and clinical pharmacists), but who interact with ASPs in their role as frontline healthcare workers.Design: Qualitative semistructured interviews.Setting: The study was conducted in 2 large national healthcare systems including 7 hospitals in the Veterans’ Health Administration and 4 hospitals in Intermountain Healthcare.Participants: We interviewed 157 participants. The current analysis includes 123 nonsteward clinicians: 47 physicians, 26 pharmacists, 29 nurses, and 21 hospital leaders.Methods: Interviewers utilized a semistructured interview guide based on the Consolidated Framework for Implementation Research (CFIR), which was tailored to the participant’s role in the hospital as it related to ASPs. Qualitative analysis was conducted using a codebook based on the CFIR.Results: We identified 4 primary perspectives regarding ASPs. (1) Non-ASP pharmacists considered antibiotic stewardship activities to be a high priority despite the added burden to work duties: (2) Nurses acknowledged limited understanding of ASP activities or involvement with these programs; (3) Physicians criticized ASPs for their restrictions on clinical autonomy and questioned the ability of antibiotic stewards to make recommendations without the full clinical picture; And (4) hospital leaders expressed support for ASPs and recognized the unique challenges faced by non-ASP clinical staff.Conclusion: Further understanding these differing perspectives of ASP implementation will inform possible ways to improve ASP implementation across clinical roles.


  • Open Access

    Outpatient treatment and clinical outcomes of bacteriuria in veterans: A retrospective cohort analysis

    by Suzette A. Rovelsky, Michelle Vu, Alexis K. Barrett, Kenneth Bukowski, Xiangming Wei, Muriel Burk, Makoto Jones, Kelly Echevarria, Katie J Suda, Francesca Cunningham, et al.

    Objective: To conduct a contemporary detailed assessment of outpatient antibiotic prescribing and outcomes for positive urine cultures in a mixed-sex cohort. Design: Multicenter retrospective cohort review. Setting: The study was conducted using data from 31 Veterans’ Affairs medical centers. Patients: Outpatient adults with positive urine cultures. Methods: From 2016 to 2019, data were extracted through a nationwide database and manual chart review. Positive urine cultures were reviewed at the chart, clinician, and aggregate levels. Cases were classified as cystitis, pyelonephritis, or asymptomatic bacteriuria (ASB) based upon documented signs and symptoms. Preferred therapy definitions were applied for subdiagnoses: ASB (no antibiotics), cystitis (trimethoprim-sulfamethoxazole, nitrofurantoin, β-lactams), and pyelonephritis (trimethoprim-sulfamethoxazole, fluoroquinolone). Outcomes included 30-day clinical failure or hospitalization. Odds ratios for outcomes between treatments were estimated using logistic regression. Results: Of 3,255 cases reviewed, ASB was identified in 1,628 cases (50%), cystitis was identified in 1,156 cases (36%), and pyelonephritis was identified in 471 cases (15%). Of all 2,831 cases, 1,298 (46%) received preferred therapy selection and duration for cases where it could be defined. The most common antibiotic class prescribed was a fluoroquinolone (34%). Patients prescribed preferred therapy had lower odds of clinical failure: preferred (8%) versus nonpreferred (10%) (unadjusted OR, 0.74; 95% confidence interval [CI], 0.58–0.95; P = .018). They also had lower odds of 30-day hospitalization: preferred therapy (3%) versus nonpreferred therapy (5%) (unadjusted OR, 0.55; 95% CI, 0.37–0.81; P = .002). Odds of clinical treatment failure or hospitalization was higher for β-lactams relative to ciprofloxacin (unadjusted OR, 1.89; 95% CI, 1.23–2.90; P = .002). Conclusions: Clinicians prescribed preferred therapy 46% of the time. Those prescribed preferred therapy had lower odds of clinical failure and of being hospitalized.


  • Implementation and outcomes of a clinician-directed intervention to improve antibiotic prescribing for acute respiratory tract infections within the Veterans’ Affairs Healthcare System

    by Karl J. Madaras-Kelly, Suzette A. Rovelsky, Robert A. McKie, McKenna R. Nevers, Jian Ying, Benjamin A. Haaland, Chad L. Kay, Melissa L. Christopher, Lauri A. Hicks, Mathew H. Samore

    Objective: To determine whether a clinician-directed acute respiratory tract infection (ARI) intervention was associated with improved antibiotic prescribing and patient outcomes across a large US healthcare system.Design: Multicenter retrospective quasi-experimental analysis of outpatient visits with a diagnosis of uncomplicated ARI over a 7-year period.Participants: Outpatients with ARI diagnoses: sinusitis, pharyngitis, bronchitis, and unspecified upper respiratory tract infection (URI-NOS). Outpatients with concurrent infection or select comorbid conditions were excluded.Intervention(s): Audit and feedback with peer comparison of antibiotic prescribing rates and academic detailing of clinicians with frequent ARI visits. Antimicrobial stewards and academic detailing personnel delivered the intervention; facility and clinician participation were voluntary.Measure(s): We calculated the probability to receive antibiotics for an ARI before and after implementation. Secondary outcomes included probability for a return clinic visits or infection-related hospitalization, before and after implementation. Intervention effects were assessed with logistic generalized estimating equation models. Facility participation was tracked, and results were stratified by quartile of facility intervention intensity.Results: We reviewed 1,003,509 and 323,023 uncomplicated ARI visits before and after the implementation of the intervention, respectively. The probability to receive antibiotics for ARI decreased after implementation (odds ratio [OR], 0.82; 95% confidence interval [CI], 0.78–0.86). Facilities with the highest quartile of intervention intensity demonstrated larger reductions in antibiotic prescribing (OR, 0.69; 95% CI, 0.59–0.80) compared to nonparticipating facilities (OR, 0.89; 95% CI, 0.73–1.09). Return visits (OR, 1.00; 95% CI, 0.94–1.07) and infection-related hospitalizations (OR, 1.21; 95% CI, 0.92–1.59) were not different before and after implementation within facilities that performed intensive implementation.Conclusions: Implementation of a nationwide ARI management intervention (ie, audit and feedback with academic detailing) was associated with improved ARI management in an intervention intensity–dependent manner. No impact on ARI-related clinical outcomes was observed.